Immune-Informed Brain Aging Research: New Treatments Possible
Summary of Research Presented: Neuro-Immune Interactions in Brain Disease
This text details research presented at a conference focusing on the interplay between the brain’s immune system and neurological diseases like parkinson’s Disease (PD) and Alzheimer’s Disease (AD). Here’s a breakdown of the key findings:
1.Gut Microbiome & Parkinson’s Disease (Schwartz Lab):
* hypothesis: The gut microbiome can contribute to PD pathology by producing bacterial amyloid proteins that nucleate alpha-synuclein in the gut. This misfolded protein then travels to the brain (potentially via the vagus nerve) and promotes disease.
* Interventions & results:
* High-Fiber Diet: increases short-chain fatty acids, modulates microglia activity in the brain, relieves motor dysfunction, reduces protein pathology.
* Drug to Disrupt Bacterial amyloid: Prevents alpha-synuclein formation in the brain and alleviates PD-like symptoms. (Results pending publication)
2. Vagus Nerve & Immune Regulation (Tracey):
* Vagus Nerve as Regulator: The vagus nerve regulates immune system cytokine emissions. Dysregulation can lead to autoimmune diseases like rheumatoid arthritis.
* Vagus Nerve Stimulation: A new FDA-approved implant stimulates the vagus nerve to treat severe rheumatoid arthritis without suppressing the immune system.
3. Brain “Borders” & Immune Function:
* Focus: Research is shifting to understanding neuro-immune interactions at the “borders” were the brain and body’s immune systems meet (meninges, choroid plexus, brain-circulatory system interface).
4. Circadian Rhythms & Alzheimer’s Disease (Stevens Lab):
* Border-Associated Macrophages: These long-lived immune cells exhibit circadian rhythms in gene expression and function.
* “Clean-Up” Function: They are more active in “eating” debris (including amyloid-beta) during the rest phase.
* Hypothesis: Circadian disruptions (aging, shift work) may impair this “clean-up” process, contributing to AD onset.
5. Macrophage Progress & Alzheimer’s Protection (Colonna Lab):
* Macrophage Differentiation: Research tracing the development of different macrophage types (border macrophages, microglia) from embryonic stages.
* Key Gene: Identified a gene crucial for border macrophages regulating CSF flow and blood flow.
* Potential Therapeutic Target: Variations in this gene might potentially be protective against AD, and regulating its expression could be a therapeutic strategy.
Overall Theme: The research highlights a growing understanding of the critical role the immune system,notably macrophages,plays in brain health and disease. It emphasizes the importance of considering factors like the gut microbiome, the vagus nerve, and circadian rhythms in understanding and potentially treating neurological disorders.